United Kingdom  

Remdesivir

Antiviral drug

Remdesivir    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Remdesivir: Antiviral drug
Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. Remdesivir is approved or authorized for emergency use to treat COVID‑19 in around 50 countries. Remdesivir has been authorized for emergency use in India, Singapore, and approved for use in Japan, the European Union, the United States, and Australia for people with severe symptoms. It also received approval in the United Kingdom in May 2020; however, it was going to be rationed due to limited supply. It may shorten the time it takes to recover from the infection.

0
shares
ShareTweetSavePostSend
 

Remdesivir has little effect on COVID deaths: WHO [Video]

Remdesivir has little effect on COVID deaths: WHO

Anti-viral medication remdesivir was found to have little or no effect on COVID-19 patients' length of hospital stay or chances of survival, according to a clinical trial by the World Health..

Credit: Reuters Studio     Duration: 01:36Published
COVID-19: Indian American Trump supporters outside Walter Reed Hospital call for prayers as President is being treated [Video]

COVID-19: Indian American Trump supporters outside Walter Reed Hospital call for prayers as President is being treated

A prayer vigil was held on Sunday evening for President Trump and First Lady Melania Trump by the Indian American community to wish them a speedy recovery. His supporters not only gathered outside the..

Credit: ANI     Duration: 02:59Published

You Might Like


Covid: Remdesivir 'has little or no effect' on survival, says WHO

Drug manufacturer Gilead has questioned the findings, from a clinical study by the WHO.
BBC News - Published

Coronavirus: US authorises use of anti-viral drug Remdesivir

The Food and Drug Administration authorises emergency use of the experimental anti-viral drug.
BBC News - Published

FDA authorizes Remdesivir drug for COVID-19

President Donald Trump said on Friday the U.S. Food and Drug Administration (FDA) had granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug Remdesivir to..
Reuters - Published
Search this site and the web: